Does switching from oral to subcutaneous administration of methotrexate influence on patient reported gastro-intestinal adverse effects? - Concepedia

Concepedia

Publication | Closed Access

Does switching from oral to subcutaneous administration of methotrexate influence on patient reported gastro-intestinal adverse effects?

23

Citations

8

References

2014

Year

Charles Kromann, Philip Rask Lage-Hansen, Mette Koefoed, Gregor B. E. Jemec

Journal of Dermatological Treatment

Abstract

Our findings support the common practice of switching from oral to SC MTX to alleviate GI AE, however, additional research is needed in order to clarify this rarely studied subject.

References

	Year	Citations

Page 1